With ~ 81 % of the human proteome on a single slide, ImmuneProfiler represents a more comprehensive and high - throughput alternative to
other assay platforms for the development of predictive early diagnostic tests.
This workshop focuses on considerations for development of a multiplexed immunoassays; examples of multiplexed
assays for research release and
other toxicities associated with CAR - T cells; and a novel flexible
platform for biomarker screening and assessment of toxicities in samples exposed to CAR - T cells.